Published in J Clin Invest on February 16, 2006
Phase 2 Study of MP4CO to Treat Vaso-occlusive Sickle Crisis | NCT01925001
The therapeutic potential of carbon monoxide. Nat Rev Drug Discov (2010) 3.03
Sickle cell disease: old discoveries, new concepts, and future promise. J Clin Invest (2007) 2.47
Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data. Blood (2008) 2.26
Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins. Blood (2012) 2.10
Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions. Am J Hematol (2009) 2.05
Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease. Blood (2013) 2.05
Malaria impairs resistance to Salmonella through heme- and heme oxygenase-dependent dysfunctional granulocyte mobilization. Nat Med (2011) 2.04
Reciprocal effects of micro-RNA-122 on expression of heme oxygenase-1 and hepatitis C virus genes in human hepatocytes. Gastroenterology (2007) 1.59
Extracellular hemin crisis triggers acute chest syndrome in sickle mice. J Clin Invest (2013) 1.58
Sickle cell disease is associated with decreased HIV but higher HBV and HCV comorbidities in U.S. hospital discharge records: a cross-sectional study. Sex Transm Infect (2012) 1.48
Heme degradation and vascular injury. Antioxid Redox Signal (2010) 1.48
Heme oxygenase in the regulation of vascular biology: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal (2010) 1.41
Ethanol-induced HO-1 and NQO1 are differentially regulated by HIF-1alpha and Nrf2 to attenuate inflammatory cytokine expression. J Biol Chem (2010) 1.27
Hemopexin prevents endothelial damage and liver congestion in a mouse model of heme overload. Am J Pathol (2008) 1.26
Heme oxygenase-1 gene promoter polymorphism is associated with reduced incidence of acute chest syndrome among children with sickle cell disease. Blood (2012) 1.26
Heme oxygenase-1 gene delivery by Sleeping Beauty inhibits vascular stasis in a murine model of sickle cell disease. J Mol Med (Berl) (2010) 1.23
Hemin causes mitochondrial dysfunction in endothelial cells through promoting lipid peroxidation: the protective role of autophagy. Am J Physiol Heart Circ Physiol (2012) 1.23
Heme in pathophysiology: a matter of scavenging, metabolism and trafficking across cell membranes. Front Pharmacol (2014) 1.20
Regulation of heme oxygenase-1 protein expression by miR-377 in combination with miR-217. J Biol Chem (2010) 1.16
Regulation of haeme oxygenase-1 for treatment of neuroinflammation and brain disorders. Br J Pharmacol (2008) 1.14
Inhaled carbon monoxide reduces leukocytosis in a murine model of sickle cell disease. Am J Physiol Heart Circ Physiol (2009) 1.08
Vascular dysfunction in a murine model of severe hemolysis. Blood (2008) 1.08
A systems biology consideration of the vasculopathy of sickle cell anemia: the need for multi-modality chemo-prophylaxsis. Cardiovasc Hematol Disord Drug Targets (2009) 1.07
Targeting heme oxygenase-1 in vascular disease. Curr Drug Targets (2010) 1.05
Evolution of novel small-molecule therapeutics targeting sickle cell vasculopathy. JAMA (2008) 1.02
Heme oxygenase, inflammation, and fibrosis: the good, the bad, and the ugly? Front Pharmacol (2012) 0.97
CO-MP4, a polyethylene glycol-conjugated haemoglobin derivative and carbon monoxide carrier that reduces myocardial infarct size in rats. Br J Pharmacol (2008) 0.96
MP4CO, a pegylated hemoglobin saturated with carbon monoxide, is a modulator of HO-1, inflammation, and vaso-occlusion in transgenic sickle mice. Blood (2013) 0.95
Heme cytotoxicity and the pathogenesis of immune-mediated inflammatory diseases. Front Pharmacol (2012) 0.94
Antisickling fetal hemoglobin reduces hypoxia-inducible factor-1α expression in normoxic sickle mice: microvascular implications. Am J Physiol Heart Circ Physiol (2012) 0.93
Anomalous renal effects of tin protoporphyrin in a murine model of sickle cell disease. Am J Pathol (2006) 0.92
Haptoglobin attenuates hemoglobin-induced heme oxygenase-1 in renal proximal tubule cells and kidneys of a mouse model of sickle cell disease. Blood Cells Mol Dis (2014) 0.91
Targeting heme oxygenase-1 and carbon monoxide for therapeutic modulation of inflammation. Transl Res (2015) 0.90
Heme oxygenase-1 deficiency alters erythroblastic island formation, steady-state erythropoiesis and red blood cell lifespan in mice. Haematologica (2015) 0.89
Gas what: NO is not the only answer to sexual function. Br J Pharmacol (2014) 0.89
Heme mediated STAT3 activation in severe malaria. PLoS One (2012) 0.88
Systemic hemin therapy attenuates blood-brain barrier disruption after intracerebral hemorrhage. Neurobiol Dis (2014) 0.87
Vasculotoxic and Proinflammatory Effects of Plasma Heme: Cell Signaling and Cytoprotective Responses. ISRN Oxidative Med (2013) 0.87
Paradoxical protection from atherosclerosis and thrombosis in a mouse model of sickle cell disease. Br J Haematol (2013) 0.87
Macrophages and Iron Metabolism. Immunity (2016) 0.86
Heme oxygenase-1 expression protects the heart from acute injury caused by inducible Cre recombinase. Lab Invest (2013) 0.86
Genetic variants and cell-free hemoglobin processing in sickle cell nephropathy. Haematologica (2015) 0.86
Haptoglobin, alpha-thalassaemia and glucose-6-phosphate dehydrogenase polymorphisms and risk of abnormal transcranial Doppler among patients with sickle cell anaemia in Tanzania. Br J Haematol (2014) 0.86
Methaemalbumin formation in sickle cell disease: effect on oxidative protein modification and HO-1 induction. Br J Haematol (2011) 0.85
Novel insights into the vasoprotective role of heme oxygenase-1. Int J Hypertens (2012) 0.84
Therapeutic approaches to limit hemolysis-driven endothelial dysfunction: scavenging free heme to preserve vasculature homeostasis. Oxid Med Cell Longev (2013) 0.84
Novel small molecule therapeutics for sickle cell disease: nitric oxide, carbon monoxide, nitrite, and apolipoprotein A-I. Hematology Am Soc Hematol Educ Program (2008) 0.84
Abnormal modulation of cell protective systems in response to ischemic/reperfusion injury is important in the development of mouse sickle cell hepatopathy. Haematologica (2010) 0.83
Amelioration of inflammation and tissue damage in sickle cell model mice by Nrf2 activation. Proc Natl Acad Sci U S A (2015) 0.83
Global gene expression profiling of endothelium exposed to heme reveals an organ-specific induction of cytoprotective enzymes in sickle cell disease. PLoS One (2011) 0.83
Dietary ω-3 fatty acids protect against vasculopathy in a transgenic mouse model of sickle cell disease. Haematologica (2015) 0.82
Role of heme in cardiovascular physiology and disease. J Am Heart Assoc (2015) 0.82
Effects of age, hemoglobin type and parasite strain on IgG recognition of Plasmodium falciparum-infected erythrocytes in Malian children. PLoS One (2013) 0.82
Heme Oxygenase-1 in Kidney Health and Disease. Antioxid Redox Signal (2016) 0.82
Heme Oxygenase-1 and Carbon Monoxide in the Heart: The Balancing Act Between Danger Signaling and Pro-Survival. Circ Res (2016) 0.82
H-ferritin ferroxidase induces cytoprotective pathways and inhibits microvascular stasis in transgenic sickle mice. Front Pharmacol (2014) 0.81
A novel hemoglobin-binding peptide reduces cell-free hemoglobin in murine hemolytic anemia. Am J Physiol Heart Circ Physiol (2012) 0.81
The proverbial chicken or the egg? Dissection of the role of cell-free hemoglobin versus reactive oxygen species in sickle cell pathophysiology. Am J Physiol Heart Circ Physiol (2008) 0.81
HO-1 and CO: fighters vs sickle cell disease? Blood (2013) 0.80
Pathophisiology of sickle cell disease and new drugs for the treatment. Mediterr J Hematol Infect Dis (2009) 0.80
Heme oxygenase-1 mediates the anti-allergic actions of quercetin in rodent mast cells. Inflamm Res (2009) 0.80
Advances in sickle cell therapies in the hydroxyurea era. Mol Med (2014) 0.80
Inflammatory targets of therapy in sickle cell disease. Transl Res (2015) 0.80
Environmental influences on daily emergency admissions in sickle-cell disease patients. Medicine (Baltimore) (2014) 0.79
The fucosylation inhibitor, 2-fluorofucose, inhibits vaso-occlusion, leukocyte-endothelium interactions and NF-ĸB activation in transgenic sickle mice. PLoS One (2015) 0.79
Sickle cell protection from malaria. Hematol Rep (2011) 0.78
Quantitative real-time polymerase chain reaction (qRT-PCR) restriction fragment length polymorphism (RFLP) method for monitoring highly conserved transgene expression during gene therapy. Transl Res (2008) 0.78
Selective enhancement of contractions to α1-adrenergic receptor activation in the aorta of mice with sickle cell disease. J Cardiovasc Pharmacol (2011) 0.78
Apolipoprotein E-/- Mice Lacking Hemopexin Develop Increased Atherosclerosis via Mechanisms That Include Oxidative Stress and Altered Macrophage Function. Arterioscler Thromb Vasc Biol (2016) 0.78
Involvement of heme oxygenase-1 in kaempferol-induced anti-allergic actions in RBL-2H3 cells. Inflammation (2009) 0.77
Methaemoglobin and COHb in patients with malaria. Malar J (2014) 0.76
Hepatic Overexpression of Hemopexin Inhibits Inflammation and Vascular Stasis in Murine Models of Sickle Cell Disease. Mol Med (2016) 0.76
Melanoma tumor growth is accelerated in a mouse model of sickle cell disease. Exp Hematol Oncol (2015) 0.75
Iron Supplementation Alters Heme and Heme Oxygenase 1 (HO-1) Levels In Pregnant Women in Ghana. SOJ Microbiol Infect Dis (2016) 0.75
Genetics of Sickle Cell-Associated Cardiovascular Disease: An Expert Review with Lessons Learned in Africa. OMICS (2016) 0.75
Heme as a Target for Therapeutic Interventions. Front Pharmacol (2017) 0.75
Role of hemoglobin/heme scavenger protein hemopexin in atherosclerosis and inflammatory diseases. Curr Opin Lipidol (2015) 0.75
Impairment of neutrophil oxidative burst in children with sickle cell disease is associated with heme oxygenase-1. Haematologica (2015) 0.75
Can gas replace protein function? CO abrogates the oxidative toxicity of myoglobin. PLoS One (2014) 0.75
Sustained treatment of sickle cell mice with haptoglobin increases HO-1 and H-ferritin expression and decreases iron deposition in the kidney without improvement in kidney function. Br J Haematol (2016) 0.75
Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol (1996) 13.14
Bilirubin is an antioxidant of possible physiological importance. Science (1987) 11.26
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med (2002) 7.59
The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol (1997) 7.50
The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta (1996) 6.15
Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol (2003) 5.34
Simultaneous determination of hemes a, b, and c from pyridine hemochrome spectra. Anal Biochem (1987) 5.10
Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest (1999) 4.66
Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease. Science (1997) 4.25
Ferritin: a cytoprotective antioxidant strategem of endothelium. J Biol Chem (1992) 4.22
Cutting edge: direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kappa B. J Immunol (2004) 3.27
Exchange of heme among hemoglobins and between hemoglobin and albumin. J Biol Chem (1968) 3.09
Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm. Proc Natl Acad Sci U S A (2002) 2.72
Different faces of the heme-heme oxygenase system in inflammation. Pharmacol Rev (2003) 2.52
Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with restenosis after percutaneous transluminal angioplasty. J Endovasc Ther (2001) 2.51
Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice. J Clin Invest (2000) 2.47
Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury. J Clin Invest (1999) 2.44
Pathology of Berkeley sickle cell mice: similarities and differences with human sickle cell disease. Blood (2005) 2.37
The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Radic Biol Med (2004) 2.27
Ferritin, iron homeostasis, and oxidative damage. Free Radic Biol Med (2002) 2.26
Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur J Biochem (1997) 2.16
Heme oxygenase/carbon monoxide signaling pathways: regulation and functional significance. Mol Cell Biochem (2002) 2.16
Pathological implications of nitric oxide, superoxide and peroxynitrite formation. Biochem Soc Trans (1993) 2.10
Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease. Blood (2004) 2.06
Transgenic sickle mice have vascular inflammation. Blood (2003) 2.03
Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase. Blood (2001) 1.88
Overexpression of wild type and mutated human ferritin H-chain in HeLa cells: in vivo role of ferritin ferroxidase activity. J Biol Chem (2000) 1.88
Hemolysis-associated priapism in sickle cell disease. Blood (2005) 1.86
Plasma concentrations of hemopexin, haptoglobin and heme in patients with various hemolytic diseases. Blood (1968) 1.81
Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress: role of bilirubin generated by the enzyme. Circ Res (1999) 1.80
Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages. Br J Pharmacol (2005) 1.80
Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation. J Immunol (2004) 1.77
Biological activity of nitric oxide in the plasmatic compartment. Proc Natl Acad Sci U S A (2004) 1.68
Reperfusion injury pathophysiology in sickle transgenic mice. Blood (2000) 1.65
Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease. Am J Pathol (2001) 1.61
Critical role of endothelial cell activation in hypoxia-induced vasoocclusion in transgenic sickle mice. Am J Physiol Heart Circ Physiol (2005) 1.57
Heme oxygenase-1 deficiency: the first autopsy case. Hum Pathol (2002) 1.53
Simvastatin induces heme oxygenase-1: a novel mechanism of vessel protection. Circulation (2004) 1.52
Accelerated autoxidation and heme loss due to instability of sickle hemoglobin. Proc Natl Acad Sci U S A (1988) 1.51
Heavy chain ferritin acts as an antiapoptotic gene that protects livers from ischemia reperfusion injury. FASEB J (2003) 1.42
An emerging role for nitric oxide in sickle cell disease vascular homeostasis and therapy. Curr Opin Hematol (2003) 1.41
Role of redox-regulated transcription factors in inflammation, aging and age-related diseases. Exp Gerontol (2000) 1.38
Ferritin: at the crossroads of iron and oxygen metabolism. J Nutr (2003) 1.34
H-ferritin subunit overexpression in erythroid cells reduces the oxidative stress response and induces multidrug resistance properties. Blood (1999) 1.32
Anti-inflammatory therapy ameliorates leukocyte adhesion and microvascular flow abnormalities in transgenic sickle mice. Am J Physiol Heart Circ Physiol (2004) 1.30
The antioxidant defense protein heme oxygenase 1 is a novel target for statins in endothelial cells. Free Radic Biol Med (2004) 1.30
S-nitrosylation: physiological regulation of NF-kappaB. Proc Natl Acad Sci U S A (2004) 1.28
Vascular cell adhesion molecule-1 is involved in mediating hypoxia-induced sickle red blood cell adherence to endothelium: potential role in sickle cell disease. Blood (1996) 1.23
Small interference RNA-mediated gene silencing of human biliverdin reductase, but not that of heme oxygenase-1, attenuates arsenite-mediated induction of the oxygenase and increases apoptosis in 293A kidney cells. J Biol Chem (2005) 1.22
Microvascular blood flow and stasis in transgenic sickle mice: utility of a dorsal skin fold chamber for intravital microscopy. Am J Hematol (2004) 1.21
Carbon monoxide protection against endotoxic shock involves reciprocal effects on iNOS in the lung and liver. FASEB J (2004) 1.19
Superoxide, H2O2, and iron are required for TNF-alpha-induced MCP-1 gene expression in endothelial cells: role of Rac1 and NADPH oxidase. Am J Physiol Heart Circ Physiol (2003) 1.19
Iron loading of endothelial cells augments oxidant damage. J Lab Clin Med (1990) 1.15
In vivo demonstration of red cell-endothelial interaction, sickling and altered microvascular response to oxygen in the sickle transgenic mouse. J Clin Invest (1995) 1.15
The contribution of endothelial cell P-selectin to the microvascular flow of mouse sickle erythrocytes in vivo. Blood (2004) 1.15
Kinetics of white blood cell staining by intravascular administration of rhodamine 6G. Int J Microcirc Clin Exp (1996) 1.12
A second generation transgenic mouse model expressing both hemoglobin S (HbS) and HbS-Antilles results in increased phenotypic severity. Blood (1995) 1.12
Interaction of bilirubin and biliverdin with reactive nitrogen species. FEBS Lett (2003) 1.11
Antioxidant activities of bile pigments: biliverdin and bilirubin. Methods Enzymol (1990) 1.11
Nitric oxide therapy in sickle cell disease. Semin Hematol (2001) 1.08
Differential effects of heme oxygenase isoforms on heme mediation of endothelial intracellular adhesion molecule 1 expression. J Pharmacol Exp Ther (1999) 1.07
N-acetylcysteine protects mice from lethal endotoxemia by regulating the redox state of immune cells. Free Radic Res (2003) 1.04
Measurement of carboxyhemoglobin and total hemoglobin by five specialized spectrophotometers (CO-oximeters) in comparison with reference methods. Clin Chem (1993) 1.03
Heme oxygenase modulates selectin expression in different regional vascular beds. Am J Physiol Heart Circ Physiol (2000) 1.02
Endothelial cell heme oxygenase and ferritin induction in rat lung by hemoglobin in vivo. Am J Physiol (1995) 1.00
The effect of carbon monoxide on red cell life span in sickle cell disease. Blood (1975) 0.97
In vivo blood flow abnormalities in the transgenic knockout sickle cell mouse. J Clin Invest (1999) 0.96
Haem, haem oxygenase and ferritin in vascular endothelial cell injury. Nephrol Dial Transplant (2003) 0.95
The panoply of animal models for sickle cell anaemia. Br J Haematol (2001) 0.91
Hemopexin metabolism in sickle-cell disease, porphyrias and control subjects--effects of heme injection. N Engl J Med (1974) 0.91
Bilirubin and S-nitrosothiols interaction: evidence for a possible role of bilirubin as a scavenger of nitric oxide. Biochem Pharmacol (2003) 0.90
Improved micro-method for determination of serum bilirubin. Clin Chim Acta (1966) 0.90
Hemopexin metabolism in patients with altered serum levels. J Lab Clin Med (1983) 0.88
Polynitroxyl albumin inhibits inflammation and vasoocclusion in transgenic sickle mice. J Lab Clin Med (2005) 0.86
Heme oxygenase-1 induction and dependent increase in ferritin. A protective antioxidant stratagem in hemin-treated rat brain. Dev Neurosci (2002) 0.85
Oxidant--nitric oxide signalling mechanisms in vascular tissue. Biochemistry (Mosc) (1998) 0.85
Development of vascular biology over the past 10 years: heme oxygenase-1 in cardiovascular homeostasis. J Endovasc Ther (2004) 0.85
Role of bilirubin in the regulation of the total peroxyl radical trapping antioxidant activity of plasma in sickle cell disease. Biochem Biophys Res Commun (1998) 0.84
Heme uptake by endothelium synergizes polymorphonuclear granulocyte-mediated damage. Trans Assoc Am Physicians (1990) 0.83
Reduction of inflammatory response in composite flap transfer by local stress conditioning-induced heat-shock protein 32. Surgery (2001) 0.82
Interaction of Fe-protoporphyrin IX and heme analogues with purified recombinant heme oxygenase-2, the constitutive isozyme of the brain and testes. J Biol Chem (1994) 0.81
Induction of heme oxygenase-1 and dilatation of hepatic sinusoids by an administration of pyrrolidine dithiocarbamate in rat livers. J Surg Res (2003) 0.80
Bilirubin and ferritin as protectors against hemin-induced oxidative stress in rat liver. Cell Mol Biol (Noisy-le-grand) (2002) 0.80
Lessons from transgenic mouse lines expressing sickle hemoglobin. Proc Soc Exp Biol Med (1994) 0.77
Serum haemopexin concentration in patients with various haemoglobinopathies. Effect of splenectomy. Acta Haematol (1973) 0.77
Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood (2003) 3.04
The therapeutic potential of carbon monoxide. Nat Rev Drug Discov (2010) 3.03
Pro-oxidant and cytotoxic effects of circulating heme. Blood (2002) 2.45
Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids. Blood (2010) 2.45
Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Res (2002) 2.45
The sedoheptulose kinase CARKL directs macrophage polarization through control of glucose metabolism. Cell Metab (2012) 2.36
Pulmonary hypertension and nitric oxide depletion in sickle cell disease. Blood (2010) 2.25
Heme oxygenase/carbon monoxide signaling pathways: regulation and functional significance. Mol Cell Biochem (2002) 2.16
Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins. Blood (2012) 2.10
Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease. Blood (2013) 2.05
Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions. Am J Hematol (2009) 2.05
Transgenic sickle mice have vascular inflammation. Blood (2003) 2.03
Autoantibodies in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2007) 1.94
Carbon monoxide in biology and medicine. Bioessays (2004) 1.91
Carbon monoxide ameliorates chronic murine colitis through a heme oxygenase 1-dependent pathway. J Exp Med (2005) 1.90
Suppression of inflammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1. J Biol Chem (2003) 1.83
Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia. Blood (2004) 1.82
Blood outgrowth endothelial cells from Hereditary Haemorrhagic Telangiectasia patients reveal abnormalities compatible with vascular lesions. Cardiovasc Res (2005) 1.76
Endothelial cell expression of tissue factor in sickle mice is augmented by hypoxia/reoxygenation and inhibited by lovastatin. Blood (2004) 1.73
Failure of fibrotic liver regeneration in mice is linked to a severe fibrogenic response driven by hepatic progenitor cell activation. Am J Pathol (2013) 1.73
Brief inhalation of low-dose carbon monoxide protects rodents and swine from postoperative ileus. Crit Care Med (2005) 1.73
Circulating endothelial cells. Biomarker of vascular disease. Thromb Haemost (2005) 1.73
Cholesterol-modified polyurethane valve cusps demonstrate blood outgrowth endothelial cell adhesion post-seeding in vitro and in vivo. Ann Thorac Surg (2006) 1.63
Hypoxia-inducible factor 1alpha stabilization by carbon monoxide results in cytoprotective preconditioning. Proc Natl Acad Sci U S A (2007) 1.61
Carbon monoxide signals via inhibition of cytochrome c oxidase and generation of mitochondrial reactive oxygen species. FASEB J (2007) 1.60
Heme oxygenase and carbon monoxide initiate homeostatic signaling. J Mol Med (Berl) (2007) 1.60
Bilirubin: a natural inhibitor of vascular smooth muscle cell proliferation. Circulation (2005) 1.60
Inhaled carbon monoxide suppresses the development of postoperative ileus in the murine small intestine. Gastroenterology (2003) 1.59
Andrographolide attenuates inflammation by inhibition of NF-kappa B activation through covalent modification of reduced cysteine 62 of p50. J Immunol (2004) 1.58
Critical role of endothelial cell activation in hypoxia-induced vasoocclusion in transgenic sickle mice. Am J Physiol Heart Circ Physiol (2005) 1.57
Heme, heme oxygenase, and ferritin: how the vascular endothelium survives (and dies) in an iron-rich environment. Antioxid Redox Signal (2007) 1.55
Differential contribution of FXa and thrombin to vascular inflammation in a mouse model of sickle cell disease. Blood (2014) 1.53
Carbon monoxide inhibition of apoptosis during ischemia-reperfusion lung injury is dependent on the p38 mitogen-activated protein kinase pathway and involves caspase 3. J Biol Chem (2002) 1.52
Blood outgrowth endothelial cell migration and trapping in vivo: a window into gene therapy. Transl Res (2009) 1.50
Biliverdin administration protects against endotoxin-induced acute lung injury in rats. Am J Physiol Lung Cell Mol Physiol (2005) 1.49
Carbon monoxide inhibits sprouting angiogenesis and vascular endothelial growth factor receptor-2 phosphorylation. Thromb Haemost (2014) 1.48
Carbon monoxide orchestrates a protective response through PPARgamma. Immunity (2006) 1.47
Carbon monoxide inhalation protects rat intestinal grafts from ischemia/reperfusion injury. Am J Pathol (2003) 1.47
Red cells, hemoglobin, heme, iron, and atherogenesis. Arterioscler Thromb Vasc Biol (2010) 1.44
Carbon monoxide induces cytoprotection in rat orthotopic lung transplantation via anti-inflammatory and anti-apoptotic effects. Am J Pathol (2003) 1.43
Heavy chain ferritin acts as an antiapoptotic gene that protects livers from ischemia reperfusion injury. FASEB J (2003) 1.42
Pilot study of vascular health in survivors of osteosarcoma. Pediatr Blood Cancer (2013) 1.42
Endothelial cell NADPH oxidase mediates the cerebral microvascular dysfunction in sickle cell transgenic mice. FASEB J (2005) 1.41
Mitochondrial DAMPs increase endothelial permeability through neutrophil dependent and independent pathways. PLoS One (2013) 1.40
Iron deficiency and diffuse nonscarring scalp alopecia in women: more pieces to the puzzle. J Am Acad Dermatol (2010) 1.39
Carbon monoxide protects against liver failure through nitric oxide-induced heme oxygenase 1. J Exp Med (2003) 1.39
Biliverdin protects the functional integrity of a transplanted syngeneic small bowel. Gastroenterology (2004) 1.39
Use of blood outgrowth endothelial cells for gene therapy for hemophilia A. Blood (2002) 1.38
Heme oxygenase-1-derived carbon monoxide protects hearts from transplant associated ischemia reperfusion injury. FASEB J (2004) 1.38
Protection against ischemia/reperfusion injury in cardiac and renal transplantation with carbon monoxide, biliverdin and both. Am J Transplant (2005) 1.36
Protection of transplant-induced renal ischemia-reperfusion injury with carbon monoxide. Am J Physiol Renal Physiol (2004) 1.33
An anti-inflammatory role for carbon monoxide and heme oxygenase-1 in chronic Th2-mediated murine colitis. J Immunol (2011) 1.31
Anti-inflammatory therapy ameliorates leukocyte adhesion and microvascular flow abnormalities in transgenic sickle mice. Am J Physiol Heart Circ Physiol (2004) 1.30
Carbon monoxide modulates endotoxin-induced production of granulocyte macrophage colony-stimulating factor in macrophages. Am J Respir Cell Mol Biol (2002) 1.27
Heme oxygenase-1 gene delivery by Sleeping Beauty inhibits vascular stasis in a murine model of sickle cell disease. J Mol Med (Berl) (2010) 1.23
Ex vivo gene therapy for hemophilia A that enhances safe delivery and sustained in vivo factor VIII expression from lentivirally engineered endothelial progenitors. Stem Cells (2007) 1.22
Transgenic sickle mice are markedly sensitive to renal ischemia-reperfusion injury. Am J Pathol (2005) 1.22
Disruption of an SP2/KLF6 repression complex by SHP is required for farnesoid X receptor-induced endothelial cell migration. J Biol Chem (2006) 1.21
Microvascular blood flow and stasis in transgenic sickle mice: utility of a dorsal skin fold chamber for intravital microscopy. Am J Hematol (2004) 1.21
Identification of novel trophoblast invasion-related genes: heme oxygenase-1 controls motility via peroxisome proliferator-activated receptor gamma. Endocrinology (2008) 1.20
Cell surface biliverdin reductase mediates biliverdin-induced anti-inflammatory effects via phosphatidylinositol 3-kinase and Akt. J Biol Chem (2009) 1.20
Carbon monoxide protection against endotoxic shock involves reciprocal effects on iNOS in the lung and liver. FASEB J (2004) 1.19
Endothelial STAT3 is essential for the protective effects of HO-1 in oxidant-induced lung injury. FASEB J (2006) 1.18
Multiple cellular mechanisms related to cyclin A1 in prostate cancer invasion and metastasis. J Natl Cancer Inst (2008) 1.18
Opioids heal ischemic wounds in the rat. Wound Repair Regen (2005) 1.17
Protective effect of arginine on oxidative stress in transgenic sickle mouse models. Free Radic Biol Med (2006) 1.17
Regulation of heme oxygenase-1 protein expression by miR-377 in combination with miR-217. J Biol Chem (2010) 1.16
Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia: analysis of graft sources and long-term outcome. J Clin Oncol (2009) 1.16
Carbon monoxide prevents multiple organ injury in a model of hemorrhagic shock and resuscitation. Shock (2005) 1.15
Carbon monoxide reverses established pulmonary hypertension. J Exp Med (2006) 1.14
Heme oxygenase-1, carbon monoxide, and bilirubin induce tolerance in recipients toward islet allografts by modulating T regulatory cells. FASEB J (2007) 1.14
Toll-like receptor 4 suppression leads to islet allograft survival. FASEB J (2007) 1.12
Carbon monoxide expedites metabolic exhaustion to inhibit tumor growth. Cancer Res (2013) 1.12
Circulating endothelial cells in pulmonary hypertension. Thromb Haemost (2003) 1.11
Carbon monoxide promotes Fas/CD95-induced apoptosis in Jurkat cells. J Biol Chem (2004) 1.10
Mouse models for studying pain in sickle disease: effects of strain, age, and acuteness. Br J Haematol (2011) 1.09
Carbon monoxide inhibits human airway smooth muscle cell proliferation via mitogen-activated protein kinase pathway. Am J Respir Cell Mol Biol (2002) 1.09
Hypoxia activates a Ca2+-permeable cation conductance sensitive to carbon monoxide and to GsMTx-4 in human and mouse sickle erythrocytes. PLoS One (2010) 1.09
Inhaled carbon monoxide reduces leukocytosis in a murine model of sickle cell disease. Am J Physiol Heart Circ Physiol (2009) 1.08
Heme oxygenase-1 promotes survival of renal cancer cells through modulation of apoptosis- and autophagy-regulating molecules. J Biol Chem (2012) 1.05
Heme, heme oxygenase and ferritin in vascular endothelial cell injury. Mol Nutr Food Res (2005) 1.05
The social network of carbon monoxide in medicine. Trends Mol Med (2012) 1.05
Carbon monoxide improves cardiac energetics and safeguards the heart during reperfusion after cardiopulmonary bypass in pigs. FASEB J (2004) 1.04
Nitric oxide-dependent bone marrow progenitor mobilization by carbon monoxide enhances endothelial repair after vascular injury. Circulation (2010) 1.04
Nanoparticle preconditioning for enhanced thermal therapies in cancer. Nanomedicine (Lond) (2011) 1.03
Critical role of endothelial cell-derived nitric oxide synthase in sickle cell disease-induced microvascular dysfunction. Free Radic Biol Med (2006) 1.03
Biliverdin inhibits Toll-like receptor-4 (TLR4) expression through nitric oxide-dependent nuclear translocation of biliverdin reductase. Proc Natl Acad Sci U S A (2011) 1.02
Establishment of outgrowth endothelial cells from peripheral blood. Nat Protoc (2012) 1.01
Carbon monoxide protects against the development of experimental necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol (2005) 1.01
Macrophages sense and kill bacteria through carbon monoxide-dependent inflammasome activation. J Clin Invest (2014) 1.00